267 related articles for article (PubMed ID: 30413189)
1. VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs.
Schub D; Assmann G; Sester U; Sester M; Schmidt T
Arthritis Res Ther; 2018 Nov; 20(1):252. PubMed ID: 30413189
[TBL] [Abstract][Full Text] [Related]
2. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
3. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis.
Krasselt M; Baerwald C; Liebert UG; Seifert O
Clin Rheumatol; 2019 Sep; 38(9):2493-2500. PubMed ID: 31028550
[TBL] [Abstract][Full Text] [Related]
5. Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis.
Almanzar G; Kienle F; Schmalzing M; Maas A; Tony HP; Prelog M
Rheumatology (Oxford); 2019 Nov; 58(11):2051-2060. PubMed ID: 31106368
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4-expression on VZV-specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections.
Schub D; Fousse M; Faßbender K; Gärtner BC; Sester U; Sester M; Schmidt T
Eur J Immunol; 2018 Jan; 48(1):151-160. PubMed ID: 28845512
[TBL] [Abstract][Full Text] [Related]
7. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
8. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
10. Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome.
Schoch J; Rohrer TR; Kaestner M; Abdul-Khaliq H; Gortner L; Sester U; Sester M; Schmidt T
J Infect Dis; 2017 May; 215(10):1619-1628. PubMed ID: 28379413
[TBL] [Abstract][Full Text] [Related]
11. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.
Kojima S; Iwamoto T; Kobayashi Y; Kato M; Takizawa F; Ida T; Suzuki J; Toda Y; Miyachi K; Iwata A; Furuta S; Ikeda K; Nakajima H
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38388170
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era.
Cacciapaglia F; Zuccaro C; Iannone F
Clin Exp Rheumatol; 2015; 33(6):917-23. PubMed ID: 26394271
[TBL] [Abstract][Full Text] [Related]
14. The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging.
Vukmanovic-Stejic M; Sandhu D; Seidel JA; Patel N; Sobande TO; Agius E; Jackson SE; Fuentes-Duculan J; Suárez-Fariñas M; Mabbott NA; Lacy KE; Ogg G; Nestle FO; Krueger JG; Rustin MHA; Akbar AN
J Invest Dermatol; 2015 Jul; 135(7):1752-1762. PubMed ID: 25734814
[TBL] [Abstract][Full Text] [Related]
15. Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs.
Thomas K; Sfikakis PP; Boumpas D; Boki K; Vassilopoulos D
Mediterr J Rheumatol; 2017 Sep; 28(3):164-168. PubMed ID: 32185277
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
18. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.
Svane IM; Nikolajsen K; Hansen SW; Kamby C; Nielsen DL; Johnsen HE
Bone Marrow Transplant; 2002 Apr; 29(8):659-66. PubMed ID: 12180110
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
[TBL] [Abstract][Full Text] [Related]
20. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
